Sansonetti PJ - Search Results

1

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.

Sadorge C, Ndiaye A, Beveridge N, Frazer S, Giemza R, Jolly N, Johnson J, Liddy H, Cosgrove CA, Allavena P, Mantovani A, Béchet S, Fontaine-Thompson A, Griffin GE, Dupont F, Sansonetti PJ, Lewis DJ. Sadorge C, et al. Among authors: sansonetti pj. Vaccine. 2008 Feb 13;26(7):978-87. doi: 10.1016/j.vaccine.2007.11.024. Epub 2007 Dec 3. Vaccine. 2008. PMID: 18207287 Clinical Trial.

2

OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis.

Sansonetti PJ, Arondel J, Fontaine A, d'Hauteville H, Bernardini ML. Sansonetti PJ, et al. Vaccine. 1991 Jun;9(6):416-22. doi: 10.1016/0264-410x(91)90128-s. Vaccine. 1991. PMID: 1887672

3

Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.

Fontaine A, Arondel J, Sansonetti PJ. Fontaine A, et al. Among authors: sansonetti pj. Res Microbiol. 1990 Sep-Oct;141(7-8):907-12. doi: 10.1016/0923-2508(90)90129-e. Res Microbiol. 1990. PMID: 2101481 Free article.

4

Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.

Sansonetti PJ, Arondel J. Sansonetti PJ, et al. Vaccine. 1989 Oct;7(5):443-50. doi: 10.1016/0264-410x(89)90160-6. Vaccine. 1989. PMID: 2683460

5

Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

Fontaine A, Arondel J, Sansonetti PJ. Fontaine A, et al. Among authors: sansonetti pj. Infect Immun. 1988 Dec;56(12):3099-109. doi: 10.1128/iai.56.12.3099-3109.1988. Infect Immun. 1988. PMID: 3053452 Free PMC article.

6

Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.

Phalipon A, Sansonetti P. Phalipon A, et al. Biologicals. 1995 Jun;23(2):125-34. doi: 10.1006/biol.1995.0023. Biologicals. 1995. PMID: 7546655 Review.

7

Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier.

Barzu S, Fontaine A, Sansonetti P, Phalipon A. Barzu S, et al. Infect Immun. 1996 Apr;64(4):1190-6. doi: 10.1128/iai.64.4.1190-1196.1996. Infect Immun. 1996. PMID: 8606077 Free PMC article.

8

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

Coster TS, Hoge CW, VanDeVerg LL, Hartman AB, Oaks EV, Venkatesan MM, Cohen D, Robin G, Fontaine-Thompson A, Sansonetti PJ, Hale TL. Coster TS, et al. Among authors: sansonetti pj. Infect Immun. 1999 Jul;67(7):3437-43. doi: 10.1128/IAI.67.7.3437-3443.1999. Infect Immun. 1999. PMID: 10377124 Free PMC article.

9

Cytotoxicity and interleukin-1beta processing following Shigella flexneri infection of human monocyte-derived dendritic cells.

Edgeworth JD, Spencer J, Phalipon A, Griffin GE, Sansonetti PJ. Edgeworth JD, et al. Among authors: sansonetti pj. Eur J Immunol. 2002 May;32(5):1464-71. doi: 10.1002/1521-4141(200205)32:5<1464::AID-IMMU1464>3.0.CO;2-G. Eur J Immunol. 2002. PMID: 11981835 Free article.

10

Human monocytes kill Shigella flexneri but then die by apoptosis associated with suppression of proinflammatory cytokine production.

Hathaway LJ, Griffin GE, Sansonetti PJ, Edgeworth JD. Hathaway LJ, et al. Among authors: sansonetti pj. Infect Immun. 2002 Jul;70(7):3833-42. doi: 10.1128/IAI.70.7.3833-3842.2002. Infect Immun. 2002. PMID: 12065527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters